eNauka - pregled
Pregled prema Projekat UCB Biopharma
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2025 | Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study | Hess, Andreas; ...; Damjanov, Nemanja S; ...; (broj, koautora 27) | Article | 21aM21a |
| 2020 | Longitudinal Change in the Central Nervous System Pain Response After Treatment with Certolizumab Or Placebo. a Post-Hoc Analysis from the Precepra Trial | Rech, J; ...; Damjanov, Nemanja S; ...; (broj, koautora 24) | Conference Paper | Mp. category will be shown later |
| 2020 | Prediction of Response to Certolizumab Pegol Treatment by Functional Mri of the Brain: An International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial (Precepra) | Rech, Juergen; ...; Damjanov, Nemanja S; ...; (broj, koautora 24) | Conference Paper | Mp. category will be shown later |